These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
346 related articles for article (PubMed ID: 17714757)
1. Assessment of bone marrow plasma cell infiltrates in multiple myeloma: the added value of CD138 immunohistochemistry. Al-Quran SZ; Yang L; Magill JM; Braylan RC; Douglas-Nikitin VK Hum Pathol; 2007 Dec; 38(12):1779-87. PubMed ID: 17714757 [TBL] [Abstract][Full Text] [Related]
2. Neural cell adhesion molecule expression in plasma cells in bone marrow biopsies and aspirates allows discrimination between multiple myeloma, monoclonal gammopathy of uncertain significance and polyclonal plasmacytosis. Martín P; Santón A; Bellas C Histopathology; 2004 Apr; 44(4):375-80. PubMed ID: 15049904 [TBL] [Abstract][Full Text] [Related]
3. Quantification of bone marrow plasma cell infiltration in multiple myeloma: usefulness of bone marrow aspirate clot with CD138 immunohistochemistry. Matsue K; Matsue Y; Kumata K; Usui Y; Suehara Y; Fukumoto K; Fujisawa M; Narita K; Takeuchi M Hematol Oncol; 2017 Sep; 35(3):323-328. PubMed ID: 27140172 [TBL] [Abstract][Full Text] [Related]
4. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients. Kara IO; Sahin B; Paydas S; Cetiner S Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184 [TBL] [Abstract][Full Text] [Related]
5. Plasma cell quantification in bone marrow by computer-assisted image analysis. Went P; Mayer S; Oberholzer M; Dirnhofer S Histol Histopathol; 2006 Sep; 21(9):951-6. PubMed ID: 16763944 [TBL] [Abstract][Full Text] [Related]
6. Combined evaluation of bone marrow aspirate and biopsy is superior in the prognosis of multiple myeloma. Stifter S; Babarović E; Valković T; Seili-Bekafigo I; Stemberger C; Nacinović A; Lucin K; Jonjić N Diagn Pathol; 2010 May; 5():30. PubMed ID: 20482792 [TBL] [Abstract][Full Text] [Related]
7. AngioMap is a novel image analysis algorithm for assessment of plasma cell distribution within bone marrow vascular niche. Salama ME; Lange H; Tripp SR; Kohan J; Landis ND; Krueger JS; Potts SJ Appl Immunohistochem Mol Morphol; 2014 Aug; 22(7):550-4. PubMed ID: 23958550 [TBL] [Abstract][Full Text] [Related]
8. A counting strategy for estimating plasma cell number in CD138-stained bone marrow core biopsy sections. Smith FB; Elnawawi A Ann Clin Lab Sci; 2008; 38(2):138-42. PubMed ID: 18469359 [TBL] [Abstract][Full Text] [Related]
9. The sensitivity of CD138 immunostaining of bone marrow trephine specimens for quantifying marrow involvement in MGUS and myeloma, including samples with a low percentage of plasma cells. Ng AP; Wei A; Bhurani D; Chapple P; Feleppa F; Juneja S Haematologica; 2006 Jul; 91(7):972-5. PubMed ID: 16818287 [TBL] [Abstract][Full Text] [Related]
10. Correlation of plasma cell percentages by CD138 immunohistochemistry, cyclin D1 status, and CD56 expression with clinical parameters and overall survival in plasma cell myeloma. Dunphy CH; Nies MK; Gabriel DA Appl Immunohistochem Mol Morphol; 2007 Sep; 15(3):248-54. PubMed ID: 17721267 [TBL] [Abstract][Full Text] [Related]
11. CD138/syndecan-1: a useful immunohistochemical marker of normal and neoplastic plasma cells on routine trephine bone marrow biopsies. Chilosi M; Adami F; Lestani M; Montagna L; Cimarosto L; Semenzato G; Pizzolo G; Menestrina F Mod Pathol; 1999 Dec; 12(12):1101-6. PubMed ID: 10619261 [TBL] [Abstract][Full Text] [Related]
12. Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regions. Bayer-Garner IB; Sanderson RD; Dhodapkar MV; Owens RB; Wilson CS Mod Pathol; 2001 Oct; 14(10):1052-8. PubMed ID: 11598177 [TBL] [Abstract][Full Text] [Related]
13. Automated digital enumeration of plasma cells in bone marrow trephine biopsies of multiple myeloma. Malherbe JAJ; Fuller KA; Mirzai B; Augustson BM; Erber WN J Clin Pathol; 2022 Jan; 75(1):50-57. PubMed ID: 33234694 [TBL] [Abstract][Full Text] [Related]
14. F-18 FDG uptake of bone marrow on PET/CT scan: it's correlation with CD38/CD138 expressing myeloma cells in bone marrow of patients with multiple myeloma. Ak I; Gulbas Z Ann Hematol; 2011 Jan; 90(1):81-7. PubMed ID: 20690019 [TBL] [Abstract][Full Text] [Related]
15. Haematologists usually over-estimate the percentage of CD138+ plasma cells in marrow biopsies. Chai KY; Boyke Berahmana AA; Morison IM Pathology; 2019 Oct; 51(6):647-648. PubMed ID: 31470997 [No Abstract] [Full Text] [Related]
16. Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma. Cengiz A; Arda HÜ; Döğer F; Yavaşoğlu İ; Yürekli Y; Bolaman AZ Turk J Haematol; 2018 Aug; 35(3):175-180. PubMed ID: 29806594 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of an innovative new method for quantitation of plasma cells on CD138 immunohistochemistry. Gantana E; Mashigo N; Abdullah I; Musekwa E; Lohlun R; Nell EM; Chetty C; Ntobongwana M; Chapanduka Z J Clin Pathol; 2023 Apr; 76(4):261-265. PubMed ID: 34625512 [TBL] [Abstract][Full Text] [Related]
18. CD138 (syndecan-1), a plasma cell marker immunohistochemical profile in hematopoietic and nonhematopoietic neoplasms. O'Connell FP; Pinkus JL; Pinkus GS Am J Clin Pathol; 2004 Feb; 121(2):254-63. PubMed ID: 14983940 [TBL] [Abstract][Full Text] [Related]
19. Robust isolation of malignant plasma cells in multiple myeloma. Frigyesi I; Adolfsson J; Ali M; Christophersen MK; Johnsson E; Turesson I; Gullberg U; Hansson M; Nilsson B Blood; 2014 Feb; 123(9):1336-40. PubMed ID: 24385542 [TBL] [Abstract][Full Text] [Related]
20. [Expression and clinical significance of Notch1 on the membrane of bone marrow CD38(+)CD138(+) plasma cells in the patients with multiple myeloma]. Zhao YR; Fu R; Guan J; Gao S; Liu H; Ruan EB; Qu W; Liang Y; Wang GJ; Wang XM; Liu H; Wu YH; Song J; Wang HQ; Xing LM; Wang J; Li LJ; Shao ZH Zhonghua Xue Ye Xue Za Zhi; 2012 Apr; 33(4):274-7. PubMed ID: 22781716 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]